Genmab: Pushing for growthEx-Novartis Senior VP Judith Klimovsky has joined Copenhagen-based Genmab as Executive Vice President and Chief Development Officer. The appointment is meant to pave the way for the antibody specialist … more ➔
One Nucleus: Seasoned DirectorOne Nucleus, the Cambridge-based not-for-profit membership organisation for international life science and healthcare companies, announced the appointment of Linda Summerton as a Director. Summerton … more ➔
Medherant: Chair for the clinicUniversity of Warwick spin-out Medherant Ltd has appointed Ken Cunningham as its chair right in time for the companys move into the clinical development of its novel transdermal drug delivery patch … more ➔
Applied Photophysics: Risen through the ra...Applied Photophysics, a provider of systems for the biophysical characterisation of biomolecules, has appointed Louise Madden as Chief Executive Officer. She joined Applied Photophysics in March 2014 … more ➔
Santhera: The doctor takes chargeDeveloper of treatments for neuromuscular and neuro-ophthalmological diseases Santhera Pharmaceuticals has hired Kristina Sjöblom Nygren as Chief Medical Officer and Head of Development. more ➔
Virovet: Veterinarian comes on boardBelgian ViroVet NV, which develops vaccines and antiviral drug for livestock, has named George Gunn as the newest member of its board of directors. Until early 2015, Gunn was CEO of Novartis Animal Health … more ➔
Eppendorf: Veteran supervisorPromega-founder William Linton has been elected as a member of the Supervisory Board of lab supplier Eppendorf AG. more ➔
Ixico: Taking over from the founderLondon-based brain health company Ixico has hired Giulio Cerroni as its new Chief Executive Officer. Cerroni replaced co-founder Derek Hill, who will remain on the board and serve as executive director … more ➔
Mithra Pharmaceuticals: Master of financeMithra Pharmaceuticals, a Belgian company focused on womens health, has appointed Christophe Maréchal as Chief Financial Officer. more ➔
Therachon: Pipeline builderSwiss rare genetic diseases company Therachon AG has named Luca Santarelli Chief Executive Officer and Director. Santarelli brings widespred experience from his role as Venture Partner at Versant Ventures, … more ➔
